Waycross Investment Management CO Abbott Laboratories Transaction History

Waycross Investment Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$95.53 - $114.62 $19,106 - $22,924	200 Added 7.28%	2,947 $285 Million
Q2 2023 Jul 27, 2023	SELL	$100.78 - $112.29 $2,922 - $3,256	-29 Reduced 1.04%	2,747 $299 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $5,714 - $6,726	-59 Reduced 2.08%	2,776 $281 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $269,495 - $316,159	2,835 New	2,835 $311 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Waycross Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Waycross Investment Management CO with notifications on news.